pageInfo({
    time : "1259599370782"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "INN20139920090720"
	        , headline : "UPDATE 3-Human Genome lupus drug success is classic biotech"
	        , keywords : "[Pharmaceuticals (sub-industry), Health and medicine, United States of America, Europe, Regulation and enforcement, Biotechnology, Pharmaceuticals - generic and speciality, United Kingdom, Western Europe, Business activities, Healthcare, Pharmaceuticals and biotechnology, Hot stocks, Equities, Commodities International News Service (Reuters), General news stories]"
	        , tickers : "[ZGEN.O, us;GLAX, us;BIIB, mx;LJPC, mx;GSKN, MRCG.DE, IMMU.O, GSK.L, gb;GSK, us;GSK, us;HGSI, us;IMMU, xt;RO, xt;MRK, us;ZGEN, us;VNDA, us;RHHV, us;RHHQ, us;MKGA, us;LJPC, gb;BNI, gb;AP47, de;LJPS, de;LJPF, de;LJP, de;IDPX, de;IDPS, de;IDPF, de;IDP, de;GS7, ch;RO, de;LJPX, de;MRKX, de;ZGEX, de;ZGEF, de;ZGE, de;VM4X, de;VM4F, de;VM4, de;RHOF, de;RHO, ch;MEK, HGSI.O]"
	    }
	    , channel : {
	        id : "6"
	        , name : "newsOne"
	        , title : "Top News"
	    }})